Clinical Trials
All Clinical Trials - Page 30 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT03651427N/AUnknown
Cross-sex Hormone Therapy and Neuronal Plasticity
Gonadorelin
- NCT02995330Phase 1Terminated
Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer
Gonadorelin
- NCT02715232Phase 4Unknown
Effects of Sex Steroids on the Serotonin System
Gonadorelin
- NCT02963935Phase 3Completed
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Liraglutide
- NCT02963922Phase 3Completed
Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin
Liraglutide
- NCT03021187Phase 3Completed
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin
Semaglutide
- NCT03018665Phase 4Unknown
A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese
Exenatide
- NCT02692716Phase 3Completed
A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes
Semaglutide
- NCT02476786Phase 2Recruiting
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
Gonadorelin
- NCT02860923Phase 3Completed
Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy
Exenatide
- NCT03018028Phase 3Completed
Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 Diabetes
Semaglutide
- NCT02821819Phase 4Terminated
Random-start Ovarian Stimulation in Egg-donors (ROSE)
Gonadorelin
- NCT03015220Phase 3Completed
Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetes
Semaglutide
- NCT03029351Phase 4Terminated
GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes
Exenatide
- NCT05577806N/ACompleted
DYG Versus Cetrorelix in Oocyte Donation
Gonadorelin
- NCT07481942N/ACompleted
Body Composition Assessment in Transgender Population.
Gonadorelin
- NCT03031535Phase 1Completed
Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers
Sermorelin
- NCT02979886N/AUnknown
Effects of SNP of GnRH Receptor Genes in IVF Patients
Gonadorelin
- NCT02994550EARLY_Phase 1Completed
Influence of FSH/LH Ratio in Controlled Ovarian Stimulation
Gonadorelin
- NCT03038620Phase 4Completed
Impact of Liraglutide 3.0 on Body Fat Distribution
Liraglutide
- NCT03011021Phase 1/Phase 2Unknown
Safety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune Diabetes
Liraglutide
- NCT03011008Phase 4Unknown
Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus
Liraglutide
- NCT03233178N/ACompleted
Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study
Liraglutide
- NCT02963766Phase 3Completed
A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes
Dulaglutide
- NCT03199261Phase 1Completed
A Study of Pharmacokinetic Comparison of Two Recombinant Exendin-4 Formulations in Chinese Healthy Male Subjects
Exenatide
- NCT02960022Phase 2Recruiting
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Gonadorelin
- NCT02967757N/ACompleted
In-market Utilisation of Liraglutide Used for Weight Management in Europe
Liraglutide
- NCT03054168Phase 3Unknown
Systemic Hormones and Muscle Protein Synthesis
Gonadorelin
- NCT02972645Phase 1Completed
A Study of LY3305677 in Healthy Participants
Mazdutide
- NCT02973321Phase 2Completed
A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus
Liraglutide
- NCT02976038Phase 2Terminated
Open-Label Extension Trial to Characterize the Long-term Safety and Tolerability of Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Myopathy (PMM)
Elamipretide
- NCT02871167N/AActive Not Recruiting
Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation
Gonadorelin
- NCT02973100Phase 2Completed
A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy
Dulaglutide
- NCT03017352Phase 2Completed
Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases
Exenatide
- NCT02970942Phase 2Completed
Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.
Semaglutide
- NCT02799602Phase 3Completed
Darolutamide in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer
Gonadorelin
- NCT02941926Phase 3Completed
Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC
Gonadorelin
- NCT02920359Phase 1Completed
Generation of Positive Biological Samples to Leuprolide Acetate for Doping Control
Gonadorelin
- NCT04292548N/ACompleted
Salivary TAS, TOS, LL-37 and Dental Status in Passive Smoking Children
Ll-37
- NCT03182296N/AUnknown
Visualizing Beta Cells in Patients With a History of Gestational Diabetes
Exenatide
- NCT02962492N/ACompleted
An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes
Exenatide
- NCT02974907Phase 3Completed
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2
TB-500
- NCT02976740Phase 2Unknown
SBRT Combination With rhGM-CSF and Tα1 for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy
Thymosin-Alpha-1
- NCT03639376N/ACompleted
Passive Smoking and LL-37 in Children
Ll-37
- NCT02931370N/ACompleted
Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Loss
Liraglutide
- NCT02928471N/ACompleted
Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis; Weight Loss
Liraglutide
- NCT02928614Phase 4Completed
Biomarkers in Obese Patients With Knee Osteoarthritis; Weight Maintenance
Liraglutide
- NCT02879409N/AActive Not Recruiting
HbA1c Variability in Type II Diabetes
Liraglutide
- NCT02931344N/AUnknown
Biomarkers in Obese Patients With Knee Osteoarthritis; Weight Loss
Liraglutide
- NCT02954627N/ACompleted
Ultrasound Assessment of the Carotid Intimal Medial Thickness in Obese Subjects; Weight Loss
Liraglutide